{
    "eid": "2-s2.0-85096191714",
    "title": "The change of serum FGF-23 levels predicts the progression of renal function in chronic kidney disease patients",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Biomarker",
        "CKD progression",
        "FGF-23",
        "Vitamin D"
    ],
    "authors": [
        "Kullaya Takkavatakarn",
        "Winat Kaewtan",
        "Api Chewcharat",
        "Kearkiat Praditpornsilpa",
        "Somchai Eiam-Ong",
        "Paweena Susantitaphong"
    ],
    "citedby-count": 0,
    "ref-count": 26,
    "ref-list": [
        "FGF23 in chronic kidney disease",
        "Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease",
        "Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease",
        "Elevated fibroblast growth factor 23 concentration: Prediction of mortality among chronic kidney disease patients",
        "Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) study",
        "Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review",
        "FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis",
        "Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease",
        "Fibroblast growth factor 23 and risk of CKD progression in children",
        "Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3",
        "Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort",
        "Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease",
        "Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts",
        "Relationship between estimated glomerular filtration rate and cardiovascular mortality in a Japanese cohort with long-term follow-up",
        "Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease",
        "Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention",
        "Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease",
        "Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention",
        "Fibroblast growth factor 23 predicts mortality and end-stage renal disease in a Canadian Asian Population with chronic kidney disease",
        "FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy",
        "Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD",
        "Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality",
        "KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKDMBD)",
        "Fibroblast growth factor 23 and incident CKD in type 2 diabetes",
        "The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease",
        "Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": []
}